Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis - Top-Institutions - MDSpire

Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis

  • By

  • David Castro Corredor

  • Luis Ángel Calvo Pascual

  • María B. García-Moreno García

  • April 24, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Pain Medicine
    • Clinical Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Pain Research
    • Neuroscience

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Pain Management
    • Clinical Trials

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Pain Medicine
    • Behavioral Science

  • #5

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Rheumatology
    • Chronic Pain Research
    • Clinical Epidemiology

Original Source(s)

Short-term Variations in Bodily Pain and Related Baseline Characteristics in Fibromyalgia Patients Undergoing Paraprobiotic Supplementation: A Retrospective Observational Analysis

  • by David Castro Corredor, Luis Ángel Calvo Pascual, María B. García-Moreno García

  • April 24, 2026

Related Content

Organ Damage, BMI Linked to Fatigue in SLE

Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity

Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine

Fibromyalgia Drugs Tested for Value

Investigators compare common fibromyalgia therapies.